Cellebrite DI Q2 2024 Adj. EPS $0.10 Beats $0.05 Estimate, Sales $95.714M Beat $91.963M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cellebrite DI (NASDAQ:CLBT) reported Q2 2024 earnings of $0.10 per share, doubling the analyst estimate of $0.05. Sales reached $95.714 million, surpassing the $91.963 million estimate and marking a 24.82% increase from the same period last year.
August 15, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cellebrite DI reported Q2 2024 earnings of $0.10 per share, doubling the analyst estimate of $0.05. Sales reached $95.714 million, surpassing the $91.963 million estimate and marking a 24.82% increase from the same period last year.
Cellebrite DI's strong earnings and revenue performance, significantly beating analyst estimates, is likely to positively impact its stock price in the short term. The 100% increase in EPS and 24.82% increase in sales compared to the same period last year indicate robust growth.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100